Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Epistem and sanofi-aventis enter oncology biomarker collaboration

March 17, 2011

Genfit and sanofi-aventis sign new agreement to develop drugs for metabolic disorders

March 17, 2011

Cleveland Clinic grants Apeiron option to license SHP-1 inhibitors

March 16, 2011

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

March 16, 2011

Boehringer Ingelheim obtains rights to Acuform technology and Glumetza data

March 16, 2011

Seattle Genetics and Millennium extend antibody-drug conjugate agreement

March 16, 2011

Meiji Seika and RaQualia enter into license agreement for ziprasidone in Japan

March 15, 2011

ChronTech initiates phase IIb trial of its HCV DNA vaccine with Inovio's MedPulser delivery device

March 15, 2011

Collaboration established for research into beta-cell regeneration in diabetes

March 14, 2011

CTI gains rights to Chroma Therapeutics' antitumor drug tosedostat in the Americas

March 14, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...